| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.8 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.9 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.007 | 0.9 |